The primary endpoint of dyspnea amelioration (7 points Likert Scale) was not achieved but a favorable trend was observed with higher doses and also a reduction in episodes of worsening of HF.
← all excerpts
New perspective in heart failure management: could myosin activators be the answer?
1
—
—